本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Nurix Therapeutics

9.77
+0.05000.51%
盘后9.73-0.0400-0.41%19:55 EDT
成交量:88.13万
成交额:864.14万
市值:7.45亿
市盈率:-3.48
高:10.01
开:10.00
低:9.68
收:9.72
数据加载中...
2024/05/21

重要事件披露

Form 8-K - Current report
2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/12

重要事件披露

Form 8-K - Current report
2024/04/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/10

重要事件披露

Form 8-K - Current report
2024/04/09

重要事件披露

Form 8-K - Current report
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

重要事件披露

Form 8-K - Current report